PTC Therapeutics, Inc. (PTCT)
72.14
-2.02
(-2.72%)
USD |
NASDAQ |
Feb 10, 16:00
71.68
-0.46
(-0.64%)
After-Hours: 05:51
PTC Therapeutics EPS Diluted (Quarterly) : 0.195 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | -1.795 |
| Spyre Therapeutics, Inc. | -0.184 |
| Keros Therapeutics, Inc. | -0.1792 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 15.90M |
| Revenue (Quarterly) | 211.01M |
| Total Expenses (Quarterly) | 195.11M |
| Enterprise Value | 4.514B |
| Gross Profit Margin (Quarterly) | 88.95% |
| Profit Margin (Quarterly) | 7.53% |
| Earnings Yield | 11.86% |
| Operating Earnings Yield | 15.55% |
| Normalized Earnings Yield | 13.70 |